These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 24433444)
1. Vanadium Complexes with Hydrazone or Thiosemicarbazone Ligands as Potential Anti-Mycobacterium tuberculosis Agents. de Souza PC; Maia PI; de Barros HB; Leite CQ; Deflon VM; Pavan FR Curr Clin Pharmacol; 2015; 10(1):66-72. PubMed ID: 24433444 [TBL] [Abstract][Full Text] [Related]
2. Manganese(II) complexes with thiosemicarbazones as potential anti-Mycobacterium tuberculosis agents. Oliveira CG; da S Maia PI; Souza PC; Pavan FR; Leite CQ; Viana RB; Batista AA; Nascimento OR; Deflon VM J Inorg Biochem; 2014 Mar; 132():21-9. PubMed ID: 24188534 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antituberculosis activity of indole-pyridine derived hydrazides, hydrazide-hydrazones, and thiosemicarbazones. Velezheva V; Brennan P; Ivanov P; Kornienko A; Lyubimov S; Kazarian K; Nikonenko B; Majorov K; Apt A Bioorg Med Chem Lett; 2016 Feb; 26(3):978-985. PubMed ID: 26725953 [TBL] [Abstract][Full Text] [Related]
4. Vanadium-induced formation of thiadiazole and thiazoline compounds. Mononuclear and dinuclear oxovanadium(v) complexes with open-chain and cyclized thiosemicarbazone ligands. Rubcić M; Milić D; Horvat G; Dilović I; Galić N; Tomisić V; Cindrić M Dalton Trans; 2009 Nov; (44):9914-23. PubMed ID: 19885541 [TBL] [Abstract][Full Text] [Related]
5. Two Vanadium(V) Complexes Derived from Bromo and Chloro-Substituted Hydrazone Ligands: Syntheses, Crystal Structures and Antimicrobial Property. Sun ZQ; Yu SF; Xu XL; Qiu XY; Liu SJ Acta Chim Slov; 2020 Dec; 67(4):1281-1289. PubMed ID: 33533465 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes. Maurya MR; Agarwal S; Abid M; Azam A; Bader C; Ebel M; Rehder D Dalton Trans; 2006 Feb; (7):937-47. PubMed ID: 16462954 [TBL] [Abstract][Full Text] [Related]
7. Discovery of new antitubercular oxazolyl thiosemicarbazones. Sriram D; Yogeeswari P; Thirumurugan R; Pavana RK J Med Chem; 2006 Jun; 49(12):3448-50. PubMed ID: 16759086 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antimicrobial activity of tetradentate ligands bearing hydrazone and/or thiosemicarbazone motifs and their diorganotin(IV) complexes. González-García C; Mata A; Zani F; Mendiola MA; López-Torres E J Inorg Biochem; 2016 Oct; 163():118-130. PubMed ID: 27426049 [TBL] [Abstract][Full Text] [Related]
9. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents. Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, structural characterization and antimicrobial activities of 12 zinc(II) complexes with four thiosemicarbazone and two semicarbazone ligands. Kasuga NC; Sekino K; Ishikawa M; Honda A; Yokoyama M; Nakano S; Shimada N; Koumo C; Nomiya K J Inorg Biochem; 2003 Aug; 96(2-3):298-310. PubMed ID: 12888265 [TBL] [Abstract][Full Text] [Related]
11. Enhancement in anti-tubercular activity of indole based thiosemicarbazones on complexation with copper(I) and silver(I) halides: Structure elucidation, evaluation and molecular modelling. Khan A; Jasinski JP; Smolenski VA; Hotchkiss EP; Kelley PT; Shalit ZA; Kaur M; Paul K; Sharma R Bioorg Chem; 2018 Oct; 80():303-318. PubMed ID: 29986180 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, Spectroscopic, In-vitro and Computational Analysis of Hydrazones as Potential Antituberculosis Agents: (Part-I). Thorat BR; Rani D; Yamgar RS; Mali SN Comb Chem High Throughput Screen; 2020; 23(5):392-401. PubMed ID: 32209038 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterisation and catalytic potential of hydrazonato-vanadium(V) model complexes with [VO]3+ and [VO2]+ cores. Maurya MR; Agarwal S; Bader C; Ebel M; Rehder D Dalton Trans; 2005 Feb; (3):537-44. PubMed ID: 15672198 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial, antifungal and in vitro antileukaemia activity of metal complexes with thiosemicarbazones. Pahontu E; Julea F; Rosu T; Purcarea V; Chumakov Y; Petrenco P; Gulea A J Cell Mol Med; 2015 Apr; 19(4):865-78. PubMed ID: 25708540 [TBL] [Abstract][Full Text] [Related]
15. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)]. Noblía P; Vieites M; Parajón-Costa BS; Baran EJ; Cerecetto H; Draper P; González M; Piro OE; Castellano EE; Azqueta A; López de Ceráin A; Monge-Vega A; Gambino D J Inorg Biochem; 2005 Feb; 99(2):443-51. PubMed ID: 15621276 [TBL] [Abstract][Full Text] [Related]
16. Dioxo- and oxovanadium(V) complexes of thiohydrazone ONS donor ligands: synthesis, characterization, reactivity, and antiamoebic activity. Maurya MR; Kumar A; Bhat AR; Azam A; Bader C; Rehder D Inorg Chem; 2006 Feb; 45(3):1260-9. PubMed ID: 16441138 [TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, reactivity, and X-ray crystal structure of some mixed-ligand oxovanadium(V) complexes: first report of binuclear oxovanadium(V) complexes containing 4,4'-bipyridine type bridge. Sutradhar M; Mukherjee G; Drew MG; Ghosh S Inorg Chem; 2006 Jun; 45(13):5150-61. PubMed ID: 16780338 [TBL] [Abstract][Full Text] [Related]